Syros Pharmaceuticals, Inc. Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • Syros Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -79.1 %, a 46.7% decline year-over-year.
  • Syros Pharmaceuticals, Inc. annual Return On Assets for 2023 was -93.7 %, a 99.9% decline from 2022.
  • Syros Pharmaceuticals, Inc. annual Return On Assets for 2022 was -46.9 %, a 19.9% decline from 2021.
  • Syros Pharmaceuticals, Inc. annual Return On Assets for 2021 was -39.1 %, a 23.7% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -93.7 -46.9 -99.9% Jan 1, 2023 Dec 31, 2023
2022 -46.9 -7.78 -19.9% Jan 1, 2022 Dec 31, 2022
2021 -39.1 +12.2 +23.7% Jan 1, 2021 Dec 31, 2021
2020 -51.3 +5.21 +9.23% Jan 1, 2020 Dec 31, 2020
2019 -56.5 -5.29 -10.3% Jan 1, 2019 Dec 31, 2019
2018 -51.2 +11.6 +18.4% Jan 1, 2018 Dec 31, 2018
2017 -62.8 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.